The global Sleeplessness and Circadian Rhythm Disorder Treatment market was valued at 830 million in 2024 and is projected to reach US$ 1109 million by 2032, at a CAGR of 4.3% during the forecast period.
Sleeplessness, also known as insomnia, and circadian rhythm disorders are two common sleep-related issues that can significantly impact an individual"s quality of life. The treatment approaches for these conditions vary and can include a combination of lifestyle changes, behavioral interventions, and medical therapies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Sleeplessness and Circadian Rhythm Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Sleeplessness and Circadian Rhythm Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleeplessness and Circadian Rhythm Disorder Treatment. This report contains market size and forecasts of Sleeplessness and Circadian Rhythm Disorder Treatment in global, including the following market information:
Global Sleeplessness and Circadian Rhythm Disorder Treatment market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Sleeplessness and Circadian Rhythm Disorder Treatment companies in 2024 (%)
Total Market by Segment:
Global Sleeplessness and Circadian Rhythm Disorder Treatment market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Sleeplessness and Circadian Rhythm Disorder Treatment market segment percentages, by Type, 2024 (%)
Drug Therapy
Light Therapy
Global Sleeplessness and Circadian Rhythm Disorder Treatment market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Sleeplessness and Circadian Rhythm Disorder Treatment market segment percentages, by Application, 2024 (%)
Hospital
Specialist Clinic
Others
Global Sleeplessness and Circadian Rhythm Disorder Treatment market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Sleeplessness and Circadian Rhythm Disorder Treatment market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sleeplessness and Circadian Rhythm Disorder Treatment revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Sleeplessness and Circadian Rhythm Disorder Treatment revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lanaform
Compass Health Brands (Carex Health)
Compumedics
Natus Medical
Teva Pharmaceuticals
Lucimed (Luminette)
Garmin
Koninklijke Philips
Mylan
Fitbit
Takeda Pharmaceutical
F.Hoffman La-Roche AG
Merck & Co. Inc.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Sumitomo Dainippon Pharma Co., Ltd
Vanda Pharmaceuticals, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sleeplessness and Circadian Rhythm Disorder Treatment, market overview.
Chapter 2: Global Sleeplessness and Circadian Rhythm Disorder Treatment market size in revenue.
Chapter 3: Detailed analysis of Sleeplessness and Circadian Rhythm Disorder Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sleeplessness and Circadian Rhythm Disorder Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Overall Market Size
2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size: 2024 VS 2032
2.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sleeplessness and Circadian Rhythm Disorder Treatment Players in Global Market
3.2 Top Global Sleeplessness and Circadian Rhythm Disorder Treatment Companies Ranked by Revenue
3.3 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Companies
3.4 Top 3 and Top 5 Sleeplessness and Circadian Rhythm Disorder Treatment Companies in Global Market, by Revenue in 2024
3.5 Global Companies Sleeplessness and Circadian Rhythm Disorder Treatment Product Type
3.6 Tier 1, Tier 2, and Tier 3 Sleeplessness and Circadian Rhythm Disorder Treatment Players in Global Market
3.6.1 List of Global Tier 1 Sleeplessness and Circadian Rhythm Disorder Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Sleeplessness and Circadian Rhythm Disorder Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Markets, 2024 & 2032
4.1.2 Drug Therapy
4.1.3 Light Therapy
4.2 Segmentation by Type - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue & Forecasts
4.2.1 Segmentation by Type - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2024 & 2032
5.1.2 Hospital
5.1.3 Specialist Clinic
5.1.4 Others
5.2 Segmentation by Application - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue & Forecasts
5.2.1 Segmentation by Application - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2024 & 2032
6.2 By Region - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue & Forecasts
6.2.1 By Region - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2020-2025
6.2.2 By Region - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2026-2032
6.2.3 By Region - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2020-2032
6.3.2 United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.3.3 Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.3.4 Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2020-2032
6.4.2 Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.4.3 France Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.4.4 U.K. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.4.5 Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.4.6 Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.4.7 Nordic Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.4.8 Benelux Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2020-2032
6.5.2 China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.5.3 Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.5.4 South Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.5.5 Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.5.6 India Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2020-2032
6.6.2 Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.6.3 Argentina Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, 2020-2032
6.7.2 Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.7.3 Israel Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.7.4 Saudi Arabia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
6.7.5 UAE Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, 2020-2032
7 Companies Profiles
7.1 Lanaform
7.1.1 Lanaform Corporate Summary
7.1.2 Lanaform Business Overview
7.1.3 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.1.4 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.1.5 Lanaform Key News & Latest Developments
7.2 Compass Health Brands (Carex Health)
7.2.1 Compass Health Brands (Carex Health) Corporate Summary
7.2.2 Compass Health Brands (Carex Health) Business Overview
7.2.3 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.2.4 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.2.5 Compass Health Brands (Carex Health) Key News & Latest Developments
7.3 Compumedics
7.3.1 Compumedics Corporate Summary
7.3.2 Compumedics Business Overview
7.3.3 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.3.4 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.3.5 Compumedics Key News & Latest Developments
7.4 Natus Medical
7.4.1 Natus Medical Corporate Summary
7.4.2 Natus Medical Business Overview
7.4.3 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.4.4 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.4.5 Natus Medical Key News & Latest Developments
7.5 Teva Pharmaceuticals
7.5.1 Teva Pharmaceuticals Corporate Summary
7.5.2 Teva Pharmaceuticals Business Overview
7.5.3 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.5.4 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.5.5 Teva Pharmaceuticals Key News & Latest Developments
7.6 Lucimed (Luminette)
7.6.1 Lucimed (Luminette) Corporate Summary
7.6.2 Lucimed (Luminette) Business Overview
7.6.3 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.6.4 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.6.5 Lucimed (Luminette) Key News & Latest Developments
7.7 Garmin
7.7.1 Garmin Corporate Summary
7.7.2 Garmin Business Overview
7.7.3 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.7.4 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.7.5 Garmin Key News & Latest Developments
7.8 Koninklijke Philips
7.8.1 Koninklijke Philips Corporate Summary
7.8.2 Koninklijke Philips Business Overview
7.8.3 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.8.4 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.8.5 Koninklijke Philips Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Corporate Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.9.4 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.9.5 Mylan Key News & Latest Developments
7.10 Fitbit
7.10.1 Fitbit Corporate Summary
7.10.2 Fitbit Business Overview
7.10.3 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.10.4 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.10.5 Fitbit Key News & Latest Developments
7.11 Takeda Pharmaceutical
7.11.1 Takeda Pharmaceutical Corporate Summary
7.11.2 Takeda Pharmaceutical Business Overview
7.11.3 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.11.4 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.11.5 Takeda Pharmaceutical Key News & Latest Developments
7.12 F.Hoffman La-Roche AG
7.12.1 F.Hoffman La-Roche AG Corporate Summary
7.12.2 F.Hoffman La-Roche AG Business Overview
7.12.3 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.12.4 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.12.5 F.Hoffman La-Roche AG Key News & Latest Developments
7.13 Merck & Co. Inc.
7.13.1 Merck & Co. Inc. Corporate Summary
7.13.2 Merck & Co. Inc. Business Overview
7.13.3 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.13.4 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.13.5 Merck & Co. Inc. Key News & Latest Developments
7.14 Pfizer, Inc.
7.14.1 Pfizer, Inc. Corporate Summary
7.14.2 Pfizer, Inc. Business Overview
7.14.3 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.14.4 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.14.5 Pfizer, Inc. Key News & Latest Developments
7.15 Pernix Therapeutics
7.15.1 Pernix Therapeutics Corporate Summary
7.15.2 Pernix Therapeutics Business Overview
7.15.3 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.15.4 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.15.5 Pernix Therapeutics Key News & Latest Developments
7.16 Sanofi S.A.
7.16.1 Sanofi S.A. Corporate Summary
7.16.2 Sanofi S.A. Business Overview
7.16.3 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.16.4 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.16.5 Sanofi S.A. Key News & Latest Developments
7.17 Sumitomo Dainippon Pharma Co., Ltd
7.17.1 Sumitomo Dainippon Pharma Co., Ltd Corporate Summary
7.17.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
7.17.3 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.17.4 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.17.5 Sumitomo Dainippon Pharma Co., Ltd Key News & Latest Developments
7.18 Vanda Pharmaceuticals, Inc.
7.18.1 Vanda Pharmaceuticals, Inc. Corporate Summary
7.18.2 Vanda Pharmaceuticals, Inc. Business Overview
7.18.3 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Major Product Offerings
7.18.4 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in Global Market (2020-2025)
7.18.5 Vanda Pharmaceuticals, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Sleeplessness and Circadian Rhythm Disorder Treatment Market Opportunities & Trends in Global Market
Table 2. Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers in Global Market
Table 3. Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints in Global Market
Table 4. Key Players of Sleeplessness and Circadian Rhythm Disorder Treatment in Global Market
Table 5. Top Sleeplessness and Circadian Rhythm Disorder Treatment Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Share by Companies, 2020-2025
Table 8. Global Companies Sleeplessness and Circadian Rhythm Disorder Treatment Product Type
Table 9. List of Global Tier 1 Sleeplessness and Circadian Rhythm Disorder Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sleeplessness and Circadian Rhythm Disorder Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application– Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2026-2032
Table 17. By Region– Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2026-2032
Table 30. Lanaform Corporate Summary
Table 31. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 32. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 33. Lanaform Key News & Latest Developments
Table 34. Compass Health Brands (Carex Health) Corporate Summary
Table 35. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 36. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 37. Compass Health Brands (Carex Health) Key News & Latest Developments
Table 38. Compumedics Corporate Summary
Table 39. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 40. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 41. Compumedics Key News & Latest Developments
Table 42. Natus Medical Corporate Summary
Table 43. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 44. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 45. Natus Medical Key News & Latest Developments
Table 46. Teva Pharmaceuticals Corporate Summary
Table 47. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 48. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 49. Teva Pharmaceuticals Key News & Latest Developments
Table 50. Lucimed (Luminette) Corporate Summary
Table 51. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 52. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 53. Lucimed (Luminette) Key News & Latest Developments
Table 54. Garmin Corporate Summary
Table 55. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 56. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 57. Garmin Key News & Latest Developments
Table 58. Koninklijke Philips Corporate Summary
Table 59. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 60. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 61. Koninklijke Philips Key News & Latest Developments
Table 62. Mylan Corporate Summary
Table 63. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 64. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 65. Mylan Key News & Latest Developments
Table 66. Fitbit Corporate Summary
Table 67. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 68. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 69. Fitbit Key News & Latest Developments
Table 70. Takeda Pharmaceutical Corporate Summary
Table 71. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 72. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 73. Takeda Pharmaceutical Key News & Latest Developments
Table 74. F.Hoffman La-Roche AG Corporate Summary
Table 75. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 76. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 77. F.Hoffman La-Roche AG Key News & Latest Developments
Table 78. Merck & Co. Inc. Corporate Summary
Table 79. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 80. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 81. Merck & Co. Inc. Key News & Latest Developments
Table 82. Pfizer, Inc. Corporate Summary
Table 83. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 84. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 85. Pfizer, Inc. Key News & Latest Developments
Table 86. Pernix Therapeutics Corporate Summary
Table 87. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 88. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 89. Pernix Therapeutics Key News & Latest Developments
Table 90. Sanofi S.A. Corporate Summary
Table 91. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 92. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 93. Sanofi S.A. Key News & Latest Developments
Table 94. Sumitomo Dainippon Pharma Co., Ltd Corporate Summary
Table 95. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 96. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 97. Sumitomo Dainippon Pharma Co., Ltd Key News & Latest Developments
Table 98. Vanda Pharmaceuticals, Inc. Corporate Summary
Table 99. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Product Offerings
Table 100. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (US$, Mn) & (2020-2025)
Table 101. Vanda Pharmaceuticals, Inc. Key News & Latest Developments
List of Figures
Figure 1. Sleeplessness and Circadian Rhythm Disorder Treatment Product Picture
Figure 2. Sleeplessness and Circadian Rhythm Disorder Treatment Segment by Type in 2024
Figure 3. Sleeplessness and Circadian Rhythm Disorder Treatment Segment by Application in 2024
Figure 4. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2024
Figure 9. Segmentation by Type – Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application – Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
Figure 13. By Region - Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
Figure 14. By Country - North America Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
Figure 15. United States Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
Figure 19. Germany Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 20. France Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
Figure 27. China Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 31. India Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
Figure 33. Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share, 2020-2032
Figure 36. Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Sleeplessness and Circadian Rhythm Disorder Treatment Revenue, (US$, Mn), 2020-2032
Figure 40. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
